ANIK

14.20

0.70% -0.10

Dopo l'orario di chiusura: 14.22 0.02 +0.14%

Anika Therapeutics Inc (ANIK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$14.30

Aprire:

$14.3

Volume 24 ore:

92,656

Relative Volume:

0.61

Capitalizzazione di mercato:

$190.29M

Reddito:

$166.88M

Utile/perdita netta:

$-74.18M

Rapporto P/E:

-2.8008

EPS:

-5.07

Flusso di cassa netto:

$1.14M

1 W Prestazione:

+0.57%

1M Prestazione:

+39.08%

6M Prestazione:

+63.78%

1 anno Prestazione:

-6.64%

Intervallo 1D:

$14.11

$14.59

Intervallo di 1 settimana:

$13.94

$15.06

Portata 52W:

$7.8701

$16.70

Anika Therapeutics Inc Stock (ANIK) Company Profile

Nome

Anika Therapeutics Inc

Settore

Healthcare (1116)

Industria

Drug Manufacturers - Specialty & Generic (83)

Telefono

(781) 457-9000

Indirizzo

32 WIGGINS AVENUE, BEDFORD, MA

Dipendente

288

Cinguettio

Prossima data di guadagno

2025-03-12

Ultimi documenti SEC

ANIK's Discussions on Twitter

Compare ANIK vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ANIK Anika Therapeutics Inc	14.20	190.29M	166.88M	-74.18M	1.14M	-5.07
TAK Takeda Pharmaceutical Co Adr	17.77	56.14B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.62	48.81B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.03	44.67B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	28.57	33.27B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	536.12	23.50B	3.18B	1.33B	1.04B	27.90

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-17	Iniziato	B. Riley Securities	Buy
2024-11-01	Reiterato	Barrington Research	Outperform
2023-08-14	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2023-03-07	Downgrade	Barrington Research	Outperform → Mkt Perform
2022-11-09	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-14	Ripresa	Stephens	Equal-Weight
2022-03-09	Downgrade	Barrington Research	Outperform → Mkt Perform
2022-03-09	Downgrade	Stephens	Overweight → Equal-Weight
2021-11-16	Iniziato	Stephens	Overweight
2021-07-16	Iniziato	UBS	Neutral
2020-12-16	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2020-05-08	Downgrade	Barrington Research	Outperform → Mkt Perform
2020-01-21	Aggiornamento	Sidoti	Neutral → Buy
2020-01-10	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-11-05	Iniziato	BWS Financial	Sell
2019-09-24	Reiterato	Barrington Research	Outperform
2019-09-23	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Strong Buy
2019-02-22	Downgrade	First Analysis Sec	Outperform → Neutral
2019-02-22	Downgrade	Sidoti	Buy → Neutral
2018-07-27	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
2018-06-20	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2018-05-04	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-02-23	Downgrade	Barrington Research	Outperform → Mkt Perform
2018-01-24	Aggiornamento	First Analysis Sec	Equal-Weight → Overweight
2017-10-27	Reiterato	Barrington Research	Outperform
2016-05-09	Aggiornamento	Singular Research	BUY - Long-Term → Buy
2016-04-27	Downgrade	Northland Capital	Outperform → Market Perform
2016-02-26	Reiterato	Barrington Research	Outperform

Mostra tutto

Anika Therapeutics Inc Borsa (ANIK) Ultime notizie

Mar 11, 2026

Anika Therapeutics (ANIK) EVP’s RSUs Vest with Shares Withheld for Taxes - Stock Titan

Mar 11, 2026

Anika Therapeutics (ANIK) director nets RSU shares after tax withholding - Stock Titan

Mar 11, 2026

Mar 07, 2026

Anika Therapeutics Earnings Call Signals Cautious Rebound - TipRanks

Mar 07, 2026

Jobs Data: Will Anika Therapeutics Inc. (AKP) stock gain from lower interest ratesWeekly Loss Report & Capital Efficiency Focused Ideas - Naître et grandir

Mar 07, 2026

Anika Therapeutics (NASDAQ:ANIK) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat

Mar 07, 2026

Bank Watch: Is Anika Therapeutics Inc still a buy after recent gains2025 AllTime Highs & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Published on: 2026-03-07 10:02:22 - baoquankhu1.vn

Mar 06, 2026

Trigran Investments Inc. Sells 415,296 Shares of Anika Therapeutics Inc. $ANIK - MarketBeat

Mar 06, 2026

Anika signals 1%–9% revenue growth outlook for 2026 while expanding commercial channel and streamlining operations - MSN

Mar 06, 2026

Mar 04, 2026

Top 2 Health Care Stocks That May Crash This QuarterArcellx (NASDAQ:ACLX), Anika Therapeutics (NASDAQ:ANIK) - Benzinga

Mar 04, 2026

Anika Therapeutics Is Cheap, But FDA Decisions And OEM Pricing Still Rule - Finimize

Mar 04, 2026

Mar 03, 2026

Anika Therapeutics debuts Integrity and highlights portfolio at AAOS - Traders Union

Mar 03, 2026

Anika Therapeutics 2025 10-K: Revenue $112.8M, Diluted Loss per Share $(0.70) - TradingView

Mar 03, 2026

Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference - Yahoo Finance

Mar 03, 2026

Mar 02, 2026